HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomas.

AbstractINTRODUCTION:
We report the outcome of 23 patients with mesenchymal chondrosarcomas treated with surgery and radiation therapy +/- chemotherapy. The intent of the project was to review the impact of patient and treatment variables on treatment outcome, in particular with regard to extent of surgery and radiation dose.
PATIENTS AND METHODS:
Twenty-three patients with mesenchymal chondrosarcomas were treated with surgery and radiation therapy (min. dose 44 Gy; max. dose 78 Gy; median dose 60 Gy; mean dose 61 Gy).
RESULTS:
The median survival for the entire cohort of patients was 21.65 years (95% confidence interval ± 4.25). The 5- and 10-year OS was 78.6%. Median disease-free survival for the 23 patients was 7.2 years. Disease-free survival (DFS) at 3 and 5 years was 70.7% and 57.8%, respectively. The local control rate at 5 and 10 years was 89.5% (95%CI 64.1-97.3%). Only three patients experienced local failure, three patients had regional failure, and eight developed distant metastases.
CONCLUSIONS:
In this cohort of patients local tumor control was high when using a combination of surgery and radiation. There was not a clear relationship between radiation dose and local tumor control. J. Surg. Oncol. 2016;114:982-986. © 2016 Wiley Periodicals, Inc.
AuthorsKaren De Amorim Bernstein, Norbert Liebsch, Yen-Lin Chen, Andrzej Niemierko, Joseph H Schwab, Kevin Raskin, Santiago A Lozano-Calderon, Gregory Cote, David C Harmon, Edwin Choy, Alex Haynes, John Mullen, Francis J Hornicek, Thomas F DeLaney
JournalJournal of surgical oncology (J Surg Oncol) Vol. 114 Issue 8 Pg. 982-986 (Dec 2016) ISSN: 1096-9098 [Electronic] United States
PMID27790706 (Publication Type: Journal Article)
Copyright© 2016 Wiley Periodicals, Inc.
Topics
  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols
  • Bone Neoplasms (mortality, radiotherapy, surgery)
  • Chemotherapy, Adjuvant
  • Child
  • Child, Preschool
  • Chondrosarcoma, Mesenchymal (drug therapy, mortality, radiotherapy, surgery)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: